Class of 2022
Scientific Areas of Interest: Cell and Molecular Biology, Clinical Cancer Research, Hematologic Malignancies
For definitive clinical cancer research studies that have elucidated the genetic and molecular basis and heterogeneity of large B-cell lymphomas and Hodgkin lymphomas, the identification of molecular signatures of biologically distinct subsets of these diseases, as well as the development of the International Prognostic Index and rational treatment targets including modulators of the host
antitumor immune response.